Would I take that? I will take what I get. In past buyouts I've been furious at the low price, but those were companies I thought had a strong board. In this company, no one can believe anyone but the Bakers have any say in the price. I'm along for the ride.
As my handle states I agree completely.Amylins buyout was a scam ( The BOD gave 5 big buyers an additional 15%, right before a takeover.by BMY
In GHDX ,the Bakers have a proven track record.... we aint selling cheap.
taking a company private as opposed to a sale to a big pharma will yield much less to shareholders,but the Bakers would make far more money by owning 50% of a private company with a 25 Billion dollar future market.
Buyouts sometimes have low prices,with the avg premium 40%, going private the premium is half that 20%, say $35 a share.Todays news is disappointing to regular shareholders